Semi-automated in vivo solid-phase microextraction sampling and the diffusion-based interface calibration model to determine the pharmacokinetics of methoxyfenoterol and fenoterol in rats

In vivo solid-phase microextraction (SPME) can be used to sample the circulating blood of animals without the need to withdraw a representative blood sample. In this study, in vivo SPME in combination with liquid–chromatography tandem mass spectrometry (LC–MS/MS) was used to determine the pharmacokinetics of two drug analytes, R,R-fenoterol and R,R-methoxyfenoterol, administered as 5 mg kg⁻¹i.v. bolus doses to groups of 5 rats. This research illustrates, for the first time, the feasibility of the diffusion-based calibration interface model for in vivo SPME studies. To provide a constant sampling rate as required for the diffusion-based interface model, partial automation of the SPME sampling of the analytes from the circulating blood was accomplished using an automated blood sampling system. The use of the blood sampling system allowed automation of all SPME sampling steps in vivo, except for the insertion and removal of the SPME probe from the sampling interface. The results from in vivo SPME were compared to the conventional method based on blood withdrawal and sample clean up by plasma protein precipitation. Both whole blood and plasma concentrations were determined by the conventional method. The concentrations of methoxyfenoterol and fenoterol obtained by SPME generally concur with the whole blood concentrations determined by the conventional method indicating the utility of the proposed method. The proposed diffusion-based interface model has several advantages over other kinetic calibration models for in vivo SPME sampling including (i) it does not require the addition of a standard into the sample matrix during in vivo studies, (ii) it is simple and rapid and eliminates the need to pre-load appropriate standard onto the SPME extraction phase and (iii) the calibration constant for SPME can be calculated based on the diffusion coefficient, extraction time, fiber length and radius, and size of the boundary layer. In the current study, the experimental calibration constants of 338.9 ± 30 mm⁻³ and 298.5 ± 25 mm⁻³ are in excellent agreement with the theoretical calibration constants of 307.9 mm⁻³ and 316.0 mm⁻³ for fenoterol and methoxyfenoterol respectively.     

Quantitative determination of fenoterol and fenoterol derivatives in rat plasma using on-line immunoextraction and liquid chromatography/mass spectrometry

An on-line immunoextraction and liquid chromatography/mass spectrometry (LC/MS) method was developed and validated for the determination of R,R'-fenoterol, R,R'-methoxyfenoterol and R,S'-naphthylfenoterol in rat plasma. Sample preparation involved immunoextraction of analytes using an antibody raised against R,R'- and R,S'-aminofenoterol that was immobilized onto chromatographic support. LC was performed on a Waters hydrophilic interaction chromatography (HILIC) column (150 mm x 2.1mm), using an isocratic mobile phase of methanol:ammonium acetate (10mM, pH 6.8) (90:10, v/v) at a flow rate of 0.2 ml/min. The MS was operated in the single ion monitoring mode (m/z 304.2 for R,R'-fenoterol, m/z 318.1 for R,R'-methoxyfenoterol, and m/z 339.2 for R,S'-naphthylfenoterol). Optimization of analytes desorption process from the immunoextraction column was performed by factorial analysis and the sample calibration curves were made with spiked rat plasma samples containing 0.5-100 ng/ml of drugs. The cross-selectivity studies of the antibody were determined and the results suggested high selectivities toward R,R'-fenoterol, R,R'-methoxyfenoterol and R,S'-naphthylfenoterol. The accuracy of assay was more than 96% while intra- and inter-day precision of assay were less than 12.4%. Stability studies (2h benchtop, freeze/thaw, and autosampler stability) were conducted and the analytes were stable through out studies. The validated method was used to determine the plasma concentration-time profiles of drugs after oral administration to rats of R,R'-fenoterol, R,R'-methoxyfenoterol and R,S'-naphthylfenoterol.     

Determination of fenoterol and salbutamol in pharmaceutical formulations by electrogenerated chemiluminescence

Fenoterol and salbutamol were determined by electrogenerated chemiluminescence (ECL) coupled with flow injection analysis (FIA), using Ru(bpy)₃²⁺ as the luminescent substance. Fenoterol and salbutamol oxidize together with the ruthenium 2,2-bipyridyl at a platinum electrode, which leads to an increase in the luminescent intensity, and this increase is proportional to the analyte concentration. For fenoterol a linear calibration curve within the range from 1.0 × 10⁻⁵ to 1.0 × 10⁻⁴ mol l⁻¹ was obtained with a correlation coefficient of 0.998 (n = 5) and for salbutamol the linear analytical curve was also obtained in this range with a correlation coefficient of 0.995 (n = 5). The relative standard deviation was estimated as ≤2.5% for 3 × 10⁻⁵ mol l⁻¹ for fenoterol solution and as ≤1.3% for 5.0 × 10⁻⁵ mol l⁻¹ salbutamol solution for 15 successive injections. The limit of detection for fenoterol was 2.4 × 10⁻⁷ mol l⁻¹ and for salbutamol was 4.0 × 10⁻⁷ mol l⁻¹. Fenoterol and salbutamol were successfully determined in drug tablets and the soluble components of the matrix did not interfere in the luminescent emission. The results obtained using the luminescent methodology were not statistically different from those obtained by UV-spectrophotometry at 95% confidence level.     

Flow Injection Analysis of Some Phenolic Sympathomimetic Drugs

ABSTRACT

A new, rapid and economical flow-injection (FI) method for deter-mining some phenolic sympathomimetic drugs is proposed. These drugs are etilefrine hydrochloride (ET), fenoterol hydrobromide (FT), hexoprenaline sulphate (HP), orciprenaline sulphate (OP) and reproterol hydrochloride (R.T). The determination is based on the reaction of the studied phenolic sympathomimetic drugs with 4-aminoantipyrine (4-AAP) and potassium hexacyanoferrate (III). The chemical reaction variables and also the FI variables, were optimized on the basis of sensitivity, sampling rate and reagent consumption. The proposed technique was applied to the analysis of pure raw materials in concentrations ranging from 2-20 μg.ml^?1 in case of ET, 4-30 μg.ml^?1 in case of FT and OP and from 8-50 μg.ml^?1 in case of HP and RT. Samples can be introduced at rates of about 130 per hour. The suggested procedure retained its accuracy and precision when applied to the analysis of pharmaceutical dosage forms containing the corresponding drugs, as judged by the RSD (%) and students' test. The results of the analysis were found to agree statistically with those obtained by applying either the official or the referee methods. Furthermore, the validity of the results was assessed by applying the standard addition technique.     

A Stability-Indicating Spectrophotometric Method for the Determination of Fenoterol in Pharmaceutical Preparations.

ABSTRACT

A simple and highly sensitive spectrophotometric method was developed for the determination of fenoterol hydrobromide in pharmaceutical formulations. The method is based on measurement of the orange-yellow color peaking at 436 nm, produced when the drug is coupled with diazotized benzocaine in triethylamine medium. The method is applicable over the range of 0.5 – 10 μg/ml, with minimum detectability of 3.6 ng/ml (≈ 9.4×10^?9 M). The molar absorptivity is 4.61×10⁴ L. mol^?1. cm^?1. with relative standard error of 0.196%. The proposed method was successfully applied to the determination of fenoterol in its dosage forms; the mean recoveries of 99.61 ± 1.59 and 98.97 ± 1.52 for tablets and aerosols, respectively, were obtained. The results of the proposed method were favorably compared to those obtained by the official and reference methods. No i8543168 was encountered from the co-formulated drug ipratropium bromide, common excipients and alkaline induced degradation product. A proposal of the reaction pathway is presented.     

Spectrofluorimetric Determination of Fenoterol in Pharmaceuticals

A highly sensitive spectrofluorimetric method was developed for the determination of fenoterol HBr in pharmaceutical preparations. The method is based on the nitrosation of fenoterol followed by reaction with 2‐cyanoacetamide in the presence of ammonia and measuring the produced fluorescence at 380 nm after excitation at 338 nm. All the variables affecting the reaction conditions were carefully studied and optimized. Linear calibration graph was obtained in the range of 0.064–0.64 μg.mL^?1 with a correlation coefficient of 0.9999 and a relative standard deviation of 0.83%. The method was applied to dosage forms and the results obtained agreed well with those obtained by the official method. A proposal of the reaction pathway was suggested.     

固相萃取/气相色谱-质谱同时测定猪肉中4种β-激动剂类药物残留量

β-激动剂(属于苯乙胺类药物,PEAs)是一类可以引起交感神经兴奋的类似肾上腺素的药物。一些β-激动剂如克伦特罗、沙丁胺醇、特布它林、非诺特罗可使多种动物(牛、羊、猪、家禽等)体内的营养成分由脂肪组织向肌肉组织转移,从而显著提高胴体的瘦肉率和饲料转化率,因此常用做饲料